vs
Side-by-side financial comparison of STARZ ENTERTAINMENT CORP (STRZ) and Bio-Techne (TECH). Click either name above to swap in a different company.
STARZ ENTERTAINMENT CORP is the larger business by last-quarter revenue ($320.9M vs $295.9M, roughly 1.1× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -16.4%, a 29.2% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -7.5%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -40.6%).
Starz Entertainment Corp., formerly known as Lions Gate Entertainment Corporation, or simply Lionsgate, is a Canadian-American entertainment company currently headquartered in Santa Monica, California. Founded by Frank Giustra on July 10, 1997, it is/was domiciled and incorporated in Vancouver, British Columbia.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
STRZ vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $320.9M | $295.9M |
| Net Profit | $-52.6M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | -10.8% | 18.4% |
| Net Margin | -16.4% | 12.8% |
| Revenue YoY | -7.5% | -6.4% |
| Net Profit YoY | -71.9% | 68.3% |
| EPS (diluted) | $-3.15 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $320.9M | — | ||
| Q2 25 | $319.7M | $317.0M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | $970.5M | $297.0M | ||
| Q3 24 | $346.9M | $289.5M | ||
| Q2 24 | $347.6M | $306.1M | ||
| Q1 24 | — | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-52.6M | — | ||
| Q2 25 | $-42.5M | $-17.7M | ||
| Q1 25 | — | $22.6M | ||
| Q4 24 | $-21.9M | $34.9M | ||
| Q3 24 | $-30.6M | $33.6M | ||
| Q2 24 | $4.2M | $40.6M | ||
| Q1 24 | — | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | -10.8% | — | ||
| Q2 25 | -8.4% | -7.5% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | 3.7% | 16.0% | ||
| Q3 24 | -4.9% | 13.8% | ||
| Q2 24 | 2.9% | 15.0% | ||
| Q1 24 | — | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -16.4% | — | ||
| Q2 25 | -13.3% | -5.6% | ||
| Q1 25 | — | 7.1% | ||
| Q4 24 | -2.3% | 11.7% | ||
| Q3 24 | -8.8% | 11.6% | ||
| Q2 24 | 1.2% | 13.3% | ||
| Q1 24 | — | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-3.15 | — | ||
| Q2 25 | $-2.54 | $-0.11 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | $-0.09 | $0.22 | ||
| Q3 24 | $-1.83 | $0.21 | ||
| Q2 24 | $0.26 | $0.26 | ||
| Q1 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.0M | $172.9M |
| Total DebtLower is stronger | $608.7M | $260.0M |
| Stockholders' EquityBook value | $663.2M | $2.0B |
| Total Assets | $2.0B | $2.5B |
| Debt / EquityLower = less leverage | 0.92× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $37.0M | — | ||
| Q2 25 | $51.6M | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | $200.5M | $177.5M | ||
| Q3 24 | $229.6M | $187.5M | ||
| Q2 24 | $192.5M | $152.9M | ||
| Q1 24 | — | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | $608.7M | — | ||
| Q2 25 | $611.7M | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $2.4B | $300.0M | ||
| Q3 24 | $2.1B | $300.0M | ||
| Q2 24 | $1.5B | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $663.2M | — | ||
| Q2 25 | $712.3M | $1.9B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $-168.3M | $2.1B | ||
| Q3 24 | $935.9M | $2.1B | ||
| Q2 24 | $973.1M | $2.1B | ||
| Q1 24 | — | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | $7.2B | $2.7B | ||
| Q3 24 | $7.1B | $2.7B | ||
| Q2 24 | $7.2B | $2.7B | ||
| Q1 24 | — | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.92× | — | ||
| Q2 25 | 0.86× | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | 2.24× | 0.14× | ||
| Q2 24 | 1.59× | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-26.1M | — |
| Free Cash FlowOCF − Capex | $-31.3M | — |
| FCF MarginFCF / Revenue | -9.8% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-317.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $-26.1M | — | ||
| Q2 25 | $65.4M | $98.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | $-335.3M | $84.3M | ||
| Q3 24 | $9.1M | $63.9M | ||
| Q2 24 | $-33.5M | $75.5M | ||
| Q1 24 | — | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | — | ||
| Q2 25 | $58.5M | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | $-349.3M | $77.5M | ||
| Q3 24 | $4.4M | $54.7M | ||
| Q2 24 | $-38.4M | $57.5M | ||
| Q1 24 | — | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | -9.8% | — | ||
| Q2 25 | 18.3% | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | -36.0% | 26.1% | ||
| Q3 24 | 1.3% | 18.9% | ||
| Q2 24 | -11.0% | 18.8% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 2.2% | 1.5% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | 1.4% | 2.3% | ||
| Q3 24 | 1.4% | 3.2% | ||
| Q2 24 | 1.4% | 5.9% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | -7.98× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STRZ
| Over The Top Subscription Service OTT | $222.8M | 69% |
| Linear Subscription Service | $98.1M | 31% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
